Análisis espacial e impacto ambiental en enfermedades transmisibles

Hepatitis of unknown aetiology in children – epidemiological overview of cases reported in Europe, 1 January to 16 June 2022

Vidal A.R., Vaughan A., Innocenti F., Colombe S., Nerlander L., Rachwal N., Ciancio B.C., Mougkou A., Carvalho C., Delgado E., Mook P., De Muylder G., Peeters M., Tenev T., Golkocheva-Markova E., Jensen V.V.S., Koch A., Figoni J., Brouard C., Nikolopoulou G., Zisouli A., Murphy N., Broderick A., Goldberg L., Rich R., Sagie L.H., Tosti M.E., Suligoi B., Joosten R., Pijnacker R., Fjeldheim I., Heen E., Stȩpień M., Polański P., Marinho R.T., Martins J.V., Varela C., Avellón A., Andersson E., Mörk M.J., Mandal S., Watson C., Coughlan L., Chand M., Neill C., Bradley D.T., Li K., O'Leary M., McInnes N., Williams C.J., Moore C., Gjini A., Duffell E., Pebody R.. Hepatitis of unknown aetiology in children – epidemiological overview of cases reported in Europe, 1 January to 16 June 2022. Euro Surveill. 2022;27(31):pii=2200483.

PUBMED DOI

Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.

Suárez-García I, Alejos B, Moreno C, Martín Torres J, Masiá M, García-Fraile LJ, Riera M, Dalmau D, Rodríguez-Rosado R, Muga R, Moreno S, Jarrín I; CoRIS cohort. J Antimicrob Chemother. 2025 Mar 3;80(3):682-691.

PUBMED DOI

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

Laniece Delaunay C, Mazagatos C, Martínez-Baz I, Túri G, Goerlitz L, Domegan L, et al. JAMA Network Open. 2024 Jul 1;7(7):e2419258.

PUBMED DOI

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.

Sharrock KC, Noori T, Axelsson M, Buti M, Diaz A, Fursa O, Hendrickx G, James C, Klavs I, Korenjak M, Maticic M, Mozalevskis A, Peters L, Rigoni R, Rosinska M, Ruutel K, Schatz E, Seyler T, Veldhuijzen I, Duffell E. PLOS Glob Public Health. 2022; 2(8): e0000841.

PUBMED DOI

Investigación